TREM1 disrupts myeloid bioenergetics and cognitive function in aging and Alzheimer disease mouse models
Edward N. Wilson(Neurosciences Institute), Congcong Wang(Stanford University), Michelle S. Swarovski(Stanford University), Kristy Zera(Stanford University), Hannah Ennerfelt(Stanford University), Qian Wang(Stanford University), Aisling M. Chaney(Stanford University), Esha Gauba(Stanford University), Javier A. Ramos Benitez(Stanford University), Yann Le Guen(Stanford University), Paras S. Minhas(Stanford University), Maharshi Panchal(Stanford University), Yuting Tan(Stanford University), Eran Blacher(Stanford University), Chinyere Agbaegbu Iweka(Stanford University), Haley C. Cropper(Stanford University), Poorva Jain(Stanford University), Qingkun Liu(Stanford University), Swapnil Mehta(Stanford University), Abigail J. Zuckerman(Stanford University), Matthew Xin(Stanford University), Jacob Umans(Stanford University), Jolie Huang(Stanford University), Aarooran S. Durairaj(Stanford University), Geidy E. Serrano(Banner Sun Health Research Institute), Thomas G. Beach(Banner Sun Health Research Institute), Michael D. Greicius(Neurosciences Institute), Michelle L. James(Neurosciences Institute), Marion S. Buckwalter(Neurosciences Institute), Melanie R. McReynolds(Pennsylvania State University), Joshua D. Rabinowitz(Princeton University), Katrin I. Andreasson(Neurosciences Institute)
Cited by 48Open Access
Abstract
Related Papers
Variant of <i>TREM2</i> Associated with the Risk of Alzheimer's Disease
Thorlákur Jónsson, Hreinn Stefánsson, Stacy Steinberg et al.|New England Journal of Medicine|2012|2.6k